 |
 |

Conservative Surgery With Radiation Therapy in Clinical Stage I and II Breast CancerResults of a 20-Year Experience
Bruce G. Haffty, MD;
Neal B. Goldberg, MD;
Marie Rose, PA;
Barbara Heil, PA;
Diana Fischer, PhD;
Malcolm Beinfield, MD;
Charles McKhann, MD;
Joseph B. Weissberg, MD
Arch Surg. 1989;124(11):1266-1270.
Abstract
Conservative surgery and radiation therapy have been increasingly utilized at Yale–New Haven (Conn) Hospital since the 1960s. This analysis represents our experience from 1962 to 1982, with a total of 281 patients having a minimum assessable follow-up of five years and a median follow-up of 7.4 years. Five- and ten-year actuarial survivals were 83% and 67%, respectively. The actuarial breast recurrence-free rate was 91% at five years and 80% at ten years. Of 31 patients having recurrences in the breast alone, the actuarial five-year survival following recurrence was 48%. Twenty-eight (90%) of these 31 recurrences were salvageable with mastectomy or repeated wedge resection. Patients experiencing an early breast recurrence (less than three years) following initial treatment had a poorer prognosis than patients having recurrences later.
(Arch Surg 1989;124:1266-1270)
Author Affiliations
From the Departments of Therapeutic Radiology (Drs Haffty, Goldberg, and Weissberg), Surgery (Drs Beinfield and McKhann), and Biostatistics (Dr Fischer), Yale University School of Medicine, New Haven, Conn; and the Department of Surgery (Mss Rose and Heil and Dr Beinfield), Norwalk (Conn) Hospital.
Footnotes
Accepted for publication Sept 1, 1988.
Reprint requests to Department of Therapeutic Radiology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510 (Dr Haffty).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma
Morrow et al.
CA Cancer J Clin 2002;52:277-300.
ABSTRACT
| FULL TEXT
Preventive health care, 1999 update: 3. Follow-up after breast cancer
Temple et al.
CMAJ 1999;161:1001-1008.
ABSTRACT
| FULL TEXT
|